DENTSPLY SIRONA (NASDAQ:XRAY) Reaches New 52-Week Low at $23.85

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) shares reached a new 52-week low on Wednesday . The company traded as low as $23.85 and last traded at $24.13, with a volume of 2323311 shares. The stock had previously closed at $24.15.

Analyst Ratings Changes

A number of research analysts recently weighed in on the company. Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. The Goldman Sachs Group cut their price objective on DENTSPLY SIRONA from $34.00 to $30.00 and set a “neutral” rating on the stock in a research note on Monday, May 6th. Evercore ISI cut their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Robert W. Baird cut their price objective on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Five analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA presently has an average rating of “Moderate Buy” and an average price target of $33.44.

DENTSPLY SIRONA Trading Down 0.9 %

The company has a 50 day moving average of $25.91 and a 200 day moving average of $29.75. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The firm has a market cap of $4.89 billion, a price-to-earnings ratio of -55.32, a price-to-earnings-growth ratio of 1.16 and a beta of 1.01.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). The company had revenue of $984.00 million during the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. DENTSPLY SIRONA’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.51 EPS. As a group, research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.98 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be given a $0.16 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.64 annualized dividend and a yield of 2.65%. DENTSPLY SIRONA’s payout ratio is -145.45%.

Insider Transactions at DENTSPLY SIRONA

In other news, Director Gregory T. Lucier bought 3,577 shares of the company’s stock in a transaction dated Friday, May 31st. The stock was bought at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the transaction, the director now directly owns 58,374 shares in the company, valued at approximately $1,631,553.30. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On DENTSPLY SIRONA

Institutional investors have recently made changes to their positions in the stock. Principal Securities Inc. acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $26,000. Headlands Technologies LLC acquired a new position in DENTSPLY SIRONA in the fourth quarter valued at about $30,000. LRI Investments LLC grew its stake in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the period. Rothschild Investment LLC acquired a new position in DENTSPLY SIRONA in the second quarter valued at about $32,000. Finally, Parkside Financial Bank & Trust grew its stake in DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after acquiring an additional 292 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.